Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing the efficacy and tolerability of Sucrosomial Iron versus Ferric Maltol in iron-deficient women with iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferric Maltol (ferric maltol)
  • Sucrosomial Iron (Ferrous iron (Sucrosomial form))

Snippet

Sponsor: Pharmanutra S.p.a. | Conditions: Anemia, Iron Deficiency Anemia (IDA) | Phase 4 | Status: RECRUITING